INDV

Indivior Pharmaceuticals, Inc.

NasdaqAdd to watchlist

$34.77

+$0.45+1.31%

Delayed · 2026-09-09T20:00:00.000Z · marketstack

2 of 47tracked managers hold this· Q2 2026

Aug 10, 2026$34.77

−$3.70−9.62%over 1M

Day range97% of range

$33.92$34.80

Session

Previous close: $34.32
Open: $34.32
Volume: 1.35M
Avg volume: -
Day high: $34.80
Day low: $33.92

Fundamentals

Visualize fundamentals and more

Market cap: 4.14B
P/E ratio: 12.11
EPS (TTM): $2.87
Dividend yield: -
Beta: 0.94
Shares outstanding: 119M

Source SEC EDGAR · 9/10/2026

Tracked investors

As of Q2 2026 · 72 days ago · next update ~14 Nov 2026· what moved this quarter, onMeasure

2 fund managers this platform follows disclosed a position here, from quarterly SEC filings up to 45 days old; a manager may have sold since without yet having to say so.

Howard Marks
Oaktree Capital Management
$251.4M
6.65%of book
Joel Greenblatt
Gotham Asset Management
$3.89M
0.01%of book

Manager	Position	Share of their book	Last change
Howard Marks Oaktree Capital Management	$251.4M	6.65%
Joel Greenblatt Gotham Asset Management	$3.89M	0.01%

Share price, with each quarter a tracked manager’s position changed shaded across the range it traded in.

303540

now

Q1 '26

Q2 '26

Hover a shaded quarter to see it moved. Who, and the range they traded in, is onBespoke

13F filings cover US-listed shares only (not cash, bonds, shorts, or private holdings) and are never a recommendation to do the same.

Risk factors, year on year

Item 1AFebruary 2026 10-KMarch 2025as filed.

added: 142
dropped: 151
re-drafted: 64

Out of 305 passages in this year’s Item 1A.

New this year

• We are subject to risks related to the manufacture and distribution of our products and must adhere to stringent manufacturing practices.

292 more passages, included withBespoke

Recent activity

2 more events, included withMeasure

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Ask about Indivior Pharmaceuticals, Inc.

The assistant answers from what INDV has actually filed: 4 annual reports filed with the SEC, 13F positions from the 2 tracked investors who hold it and 4 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Pressing one answers it here, from INDV's filings and figures. One a day without an account; a free account has its own, and no card.

See every investor holding Indivior Pharmaceuticals, Inc., and every quarter they moved.

Ten seconds, no card, and nothing to cancel.

No card, no broker connection.

Continue with Google

What an account lets you do with Indivior Pharmaceuticals, Inc.

Separate the decisions from the paperwork
Every Form 4 INDV insiders have filed, with vesting and automatic tax sales struck out: what's left is the buys and sells somebody actually chose to make.
Every filingMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: who added, who trimmed, who walked away.
Every position they holdMeasure
Interrogate the filing, not the internet
Ask anything about Indivior Pharmaceuticals, Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.